Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Stopped The trial prematurely terminated as recommended by the E-DMC because the boundary for futility has been crossed.
Conditions
- Squamous Cell Carcinoma of the Head and Neck
Interventions
- DRUG: Avelumab
- OTHER: Chemoradiation
Sponsor
Pfizer